BeiGene R&D strength (tech talent demand and pay)

What is the demand for tech talent at BeiGene? Based on job postings in the past year, “医疗卫生/美容保健类”占40.6%,“电子/电器/通信技术类”占9.8%,“计算机/网络/技术类”占8.5%,“生物/制药/化工/环保类”占7.6%,“其他(研发和技术类)”占2.1%,“科研类”占1.7%,“机械/仪器仪表类”占0.8%,“电气/能源/动力类”占0.7%,“美术/设计/创意类”占0.3%,“测绘技术”占0.2%,“咨询/顾问类”占0.1%. For reference only.

Master's degree job demand analysis at BeiGene (More)

?
Growth rate
2026 vs 2025
  • 2025: Up 143%
  • 2024: Down 71%
  • 2023: Up 9%
  • 2022: Up 32%
BeiGene master's hiring over the years:
* Hiring volume was generally low in 2020-2022 due to the pandemic

PhD job demand analysis at BeiGene (More)

?
Growth rate
2026 vs 2025
  • 2025: Up 100%
  • 2024: Down 81%
  • 2023: Down 12%
  • 2022: Up 1000%
BeiGene PhD hiring over the years: 2026: 115 more positions than 2025
* Hiring volume was generally low in 2020-2022 due to the pandemic

BeiGene honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

People who follow BeiGene also follow

BeiGene Competitors (Similar Companies)

“Research, development, and production of anti-tumor and surgical medic”
“To develop high-quality biologics that are accessible and affordable f”
“Continuously innovating to bring patients medicines that significantly”
生物科技/生物工程 药物研发 生物制药 抗肿瘤药
“Helping partners successfully develop new drugs, reducing R&D costs an”
“Accelerating global biologic drug R&D processes, reducing R&D costs, a”
“Global integrated biopharmaceutical enterprise”
制药/药业 抗肿瘤药 肿瘤检测 神经系统疾病药物
“抗衰老及癌症治疗药物研发商”
“A renowned enterprise in China's liver disease and anti-tumor fields”
“Innovative drug R&D”
“Committed to becoming an innovative leader in the field of molecular t”
“改善人们的生活质量”
生物科技/生物工程 医药 分子靶向药物 药物研发
“Large-scale pharmaceutical distribution enterprise”